MyFinsight
Home
Blog
About
Contact
Download
Download image
Unrealized gain (loss) on
marketable securities
$694K
Comprehensive loss
-$6,191K
Total other
comprehensive gain (loss)
$694K
Interest income
(expense), net
$13,756K
Net loss
-$6,885K
Total other income
(expense)
$13,705K
Other income
(expense), net
-$51K
Loss from operations
-$20,590K
Revenue
$184,420K
Total operating
expenses
$205,010K
Research and development
$137,922K
Sales, general and
administrative
$67,088K
Back
Back
Income Statement
source: myfinsight.com
Stoke Therapeutics, Inc. (STOK)
Stoke Therapeutics, Inc. (STOK)